Press release
Oncolytic Virus Cancer Therapy Market Led by U.S. as Amgen and CG Oncology Advance Innovation
Market analysis indicates the oncolytic virus cancer therapy market was valued at USD 36.9 million in 2025 and is projected to reach approximately USD 44.8 million by 2026-end before expanding significantly to USD 314.3 million by 2036, reflecting a robust CAGR of 21.5% during the 2026-2036 forecast period.
The market is expected to create an incremental opportunity of approximately USD 269.5 million between 2026 and 2036, supported by expanding clinical pipelines, increasing investment in viral immunotherapies, and growing demand for innovative cancer treatment modalities.
Quick Stats: Oncolytic Virus Cancer Therapy Market
• Market Value (2025): USD 36.9 Million
• Estimated Market Size (2026): USD 44.8 Million
• Forecast Market Value (2036): USD 314.3 Million
• CAGR (2026-2036): 21.5%
• Incremental Opportunity (2026-2036): USD 269.5 Million
• Leading Virus Type Segment (2026): Herpes Simplex Virus - 22.5% Share
• Leading Application Segment (2026): Solid Tumors - 31.2% Share
• Leading End Use Segment (2026): Hospitals - 44.1% Share
• Fastest Growing Markets: South Korea (17.1%) and Japan (16.6%)
Combination Immunotherapy Drives Market Expansion
Growing evidence supporting the use of oncolytic viruses alongside immune checkpoint inhibitors continues to strengthen market growth globally. Researchers and healthcare providers are increasingly utilizing viral therapies to improve immune system recognition of cancer cells and enhance treatment responses in difficult-to-treat tumors.
Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-16335
Rising Cancer Burden Accelerates Demand
Increasing incidence of cancer worldwide remains a major factor driving demand for innovative oncology therapies. Conventional treatment approaches often demonstrate limited effectiveness in advanced-stage tumors, creating opportunities for next-generation viral immunotherapies.
Growing demand is particularly evident in:
• Melanoma treatment
• Glioblastoma management
• Breast cancer therapy
• Lung cancer treatment
• Hematological malignancies
• Checkpoint inhibitor-resistant tumors
Regulatory Support Creates New Commercial Opportunities
Regulatory agencies across major healthcare markets continue to support the development of advanced cancer therapies through breakthrough designations, orphan drug incentives, and accelerated approval pathways.
These initiatives are helping manufacturers:
• Reduce development timelines
• Accelerate commercialization efforts
• Expand clinical trial programs
• Improve patient access to innovative therapies
• Increase investment in viral oncology research
Herpes Simplex Virus Platforms Maintain Market Leadership
Herpes simplex virus (HSV)-based therapies are expected to remain the leading virus type segment in 2026, accounting for approximately 22.5% of global market share.
Strong demand is supported by:
• Established clinical validation
• Commercial success of approved products
• Proven tumor-selective activity
• Strong compatibility with immunotherapy combinations
• Expanding late-stage clinical programs
Solid Tumor Applications Lead Clinical Adoption
Solid tumors are projected to account for approximately 31.2% of the application segment in 2026.
Clinical adoption continues to accelerate due to promising trial outcomes in several high-burden cancer indications, including melanoma, glioblastoma, breast cancer, and head-and-neck cancers.
Regional Outlook: South Korea Leads Global Growth
South Korea
South Korea is projected to be the fastest-growing market globally, expanding at a CAGR of 17.1% through 2036.
Growth is supported by:
• Strong biotechnology ecosystem
• Advanced oncology research infrastructure
• Significant government investment in immunotherapy research
• Expanding clinical trial activity
Japan
Japan is expected to grow at a CAGR of 16.6% through 2036, supported by strong immuno-oncology expertise, favorable regulatory pathways, and increasing adoption of innovative cancer therapies.
European Union
The European Union is projected to expand at a CAGR of 16.1% through 2036, benefiting from advanced therapy medicinal product regulations, robust clinical research networks, and increasing reimbursement support.
United States
The United States remains one of the largest markets globally and is expected to grow at a CAGR of 15.1% through 2036, supported by expanding use of T-VEC, strong pharmaceutical investment, and an active clinical development landscape.
Customize insights for your business strategy: https://www.futuremarketinsights.com/customization-available/rep-gb-16335
Competitive Landscape Focuses on Viral Engineering and Combination Therapies
The oncolytic virus cancer therapy market remains highly competitive, with companies focusing on enhancing viral engineering capabilities, expanding clinical evidence, and developing combination treatment strategies.
Key Industry Participants Include:
• Amgen Inc.
• Replimune Group Inc.
• Oncolytics Biotech Inc.
• Transgene SA
• Sorrento Therapeutics, Inc.
• PsiOxus Therapeutics Ltd.
• DNAtrix, Inc.
• Vyriad, Inc.
Outlook Through 2036
The oncolytic virus cancer therapy market is expected to maintain exceptional long-term growth as healthcare providers increasingly adopt innovative immunotherapy approaches for difficult-to-treat cancers.
Future market growth is expected to be supported by:
• Expanding clinical evidence for combination therapies
• Rising global cancer incidence
• Increasing regulatory support for advanced biological therapies
• Continued innovation in viral engineering technologies
• Growing investment in immuno-oncology research
• Expansion of manufacturing capabilities for viral therapeutics
Explore In-Depth Healthcare Market Insights: https://www.futuremarketinsights.com/industry-analysis/healthcare
Explore Industry Insights: https://www.futuremarketinsights.com/industry-analysis
Purchase Full Report for Detailed Insights:
https://www.futuremarketinsights.com/reports/oncolytic-virus-cancer-therapy-market
Why FMI: https://www.futuremarketinsights.com/why-fmi
Explore More Related Studies Published by FMI Research:
Automated CPR Device Market: https://www.futuremarketinsights.com/reports/automated-cpr-devices-market
Whole Genome Amplification Market: https://www.futuremarketinsights.com/reports/whole-genome-amplification-market
Veterinary Pregnancy Test Kit Market: https://www.futuremarketinsights.com/reports/veterinary-pregnancy-test-kit-market
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
About Future Market Insights (FMI)
Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncolytic Virus Cancer Therapy Market Led by U.S. as Amgen and CG Oncology Advance Innovation here
News-ID: 4536566 • Views: …
More Releases from Future Market Insight Inc
Rheumatic Heart Disease Management Market Led by India as Novartis and Pfizer Dr …
According to the latest market analysis by Future Market Insights, the global rheumatic heart disease management market is witnessing steady growth supported by increasing prevalence of rheumatic heart disease in developing regions, expanding access to cardiac healthcare services, growing adoption of minimally invasive surgical procedures, and continued advancements in valve replacement and repair technologies.
Market analysis indicates the rheumatic heart disease management market was valued at USD 1.43 billion in 2025…
Restrictive Cardiomyopathy Treatment Market Led by Japan as Pfizer and BMS Expan …
According to the latest market analysis by Future Market Insights, the global restrictive cardiomyopathy treatment market is witnessing steady growth supported by improving cardiac diagnostic capabilities, rising awareness of rare cardiomyopathies, increasing adoption of disease-modifying therapies, and growing demand for specialized cardiovascular care.
Market analysis indicates the restrictive cardiomyopathy treatment market was valued at USD 112.3 million in 2025 and is projected to reach approximately USD 118.7 million by 2026-end before…
Philippines Tourism Market Set to Reach USD 146.4 Billion by 2036 Amid Rising Do …
The Philippines tourism industry is entering a sustained growth phase driven by expanding domestic travel activity, increasing international air connectivity, rising investment in hospitality infrastructure, and strong demand for island and leisure tourism experiences. Valued at USD 82.1 billion in 2025, the industry is projected to reach USD 86.5 billion in 2026 and further expand to USD 146.4 billion by 2036, registering a CAGR of 5.4% during the forecast period.
The…
Global Travel Accessories Market Set to Reach USD 123.5 Billion by 2036 Amid Ris …
According to the latest industry analysis, the global travel accessories market is entering a strong growth phase driven by the recovery of international leisure and business travel, rapid expansion of online retail channels, rising consumer demand for premium and functional travel products, and growing popularity of experiential and adventure tourism. Valued at USD 57.5 billion in 2025, the market is projected to reach USD 61.6 billion by 2026-end and further…
More Releases for USD
Bone Cement Market Outlook USD 1,871.10M-USD 3,512.31M
How Is the Bone Cement Market Supporting the Rise of Modern Orthopedic Surgery?
The Bone Cement Market plays a critical role in modern orthopedic and spinal procedures, acting as a foundational material for joint replacement, fracture fixation, and vertebral stabilization. Bone cement is widely used to anchor implants, restore bone structure, and improve patient mobility-making it an essential component of musculoskeletal care.
In 2025, the global bone cement market was valued at…
Autologous Cell Therapy Market Outlook USD 9.31B-USD 54.83B
How Is the Autologous Cell Therapy Market Redefining the Future of Precision Medicine?
The Autologous Cell Therapy Market is rapidly emerging as one of the most transformative areas in modern healthcare, offering highly personalized treatment options for complex and chronic diseases. By using a patient's own cells to repair, replace, or regenerate damaged tissues, autologous cell therapy minimizes immune rejection risks while maximizing therapeutic effectiveness.
In 2025, the global autologous cell therapy…
US Ostomy Care and Accessories Market USD 4.03B-USD 6.75B
How Is the United States Ostomy Care and Accessories Market Evolving to Meet the Needs of a Growing Patient Population?
The United States Ostomy Care and Accessories Market plays a critical role in improving the quality of life for millions of patients who undergo life-altering surgical procedures involving the digestive or urinary systems. Ostomy care products are essential medical devices designed to manage bodily waste safely and discreetly following surgeries such…
PACS Market USD 5.59B in 2025, USD 9.73B by 2035
Picture Archiving and Communication System (PACS) Market Expands as Digital Imaging Transforms Global Healthcare
Introduction: PACS at the Core of Modern Medical Imaging
The healthcare industry is undergoing a rapid digital transformation, with medical imaging playing a critical role in diagnosis, treatment planning, and patient monitoring. At the heart of this transformation lies the Picture Archiving and Communication System (PACS)-a technology that enables the storage, retrieval, management, and sharing of medical images…
Global HEOR Market USD 1.70B-USD 6.03B
Health Economics and Outcomes Research (HEOR) Market Accelerates as Value-Based Healthcare Redefines Global Decision-Making
Introduction: The Growing Importance of HEOR in Modern Healthcare
The global healthcare industry is undergoing a profound transformation, shifting from volume-driven care models to value-based healthcare systems that prioritize patient outcomes, cost efficiency, and real-world effectiveness. At the center of this transformation lies Health Economics and Outcomes Research (HEOR)-a discipline that evaluates the economic value, clinical outcomes, and…
Foam Tape Market Outlook 2035: Industry Growth from USD USD 4.89 Billion (2025) …
The Foam Tape Market plays a vital role in modern industrial and manufacturing ecosystems. Foam tapes are pressure-sensitive adhesive products manufactured using materials such as polyurethane, polyethylene, PVC, and acrylic foam. These tapes are widely used for bonding, sealing, insulation, cushioning, vibration damping, and noise reduction across multiple industries. Their ability to replace traditional mechanical fasteners like screws, bolts, and rivets has positioned foam tapes as a preferred solution in…
